DUBLIN, Jan. 8, 2014 /PRNewswire/ — Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim’s Micardis. Actavis intends to launch the product immediately.
Filed under: GENERIC DRUG Tagged: Actavis, anthony crasto, drugs, GENERIC DRUG, medicinal chemistry, MICARDIS, organic chemistry, TELMISARTAN, world drug tracker
